GVHD-derived plasma as a priming strategy of mesenchymal stem cells

Background: Mesenchymal stem cell (MSC) therapy is an important alternative for GVHD treatment, but a third of patients fail to respond to such therapy. Therefore, strategies to enhance the immunosuppressive potential of MSCs constitute an active area of investigation. Here, we proposed an innovat...

Full description

Main Authors: Carvalho, Amandda Évelin Silva, Rodrigues, Leane Perim, Schiavinato, Josiane Lilian, Alborghetti, Marcos Rodrigo, Bettarello, Gustavo, Simões, Belinda Pinto, Neves, Francisco de Assis Rocha, Panepucci, Rodrigo Alexandre, Carvalho, Juliana Lott de, Araujo, Felipe Saldanha de
Format: Artigo
Language: Inglês
Published: BMC 2020
Subjects:
Online Access: https://repositorio.unb.br/handle/10482/39539
https://doi.org/10.1186/s13287-020-01659-x
Tags: Add Tag
No Tags, Be the first to tag this record!